Zofia Hélias‐Rodzewicz
Université de Versailles Saint-Quentin-en-Yvelines(FR)Université Paris-Saclay(FR)Assistance Publique – Hôpitaux de Paris(FR)Hôpital Ambroise-Paré(FR)Biomarqueurs et essais cliniques en Cancérologie et Onco-Hématologie(FR)
Publications by Year
Research Areas
Histiocytic Disorders and Treatments, Melanoma and MAPK Pathways, Cutaneous Melanoma Detection and Management, Mast cells and histamine, Eosinophilic Disorders and Syndromes
Most-Cited Works
- → High prevalence of BRAF V600E mutations in Erdheim-Chester disease but not in other non-Langerhans cell histiocytoses(2012)685 cited
- → BRAF Mutation Correlates With High-Risk Langerhans Cell Histiocytosis and Increased Resistance to First-Line Therapy(2016)330 cited
- → Recurrent RAS and PIK3CA mutations in Erdheim-Chester disease(2014)243 cited
- → Vemurafenib for Refractory Multisystem Langerhans Cell Histiocytosis in Children: An International Observational Study(2019)214 cited
- → Predictive role of plasmatic biomarkers in advanced non-small cell lung cancer treated by nivolumab(2018)172 cited
- → Mutational signature analysis identifies MUTYH deficiency in colorectal cancers and adrenocortical carcinomas(2017)161 cited